文献速递心血管乳腺MR

基于全自动综合MRI分析化疗后乳腺癌患者左心室收缩功能

Fully automated and comprehensive MRI-based left-ventricular contractility analysis in post-chemotherapy breast cancer patients.
PubMed 文献 · Br J Radiol · 2019-10-23

本研究用自动化的MRI左心室收缩功能分析工具,对21例化疗后乳腺癌患者和21例年龄匹配健康女性的左心室腔量化指标、三维应变及扭转进行比较。结果显示患者基底径增大、心尖扭转及整体纵向应变减低,但左心室射血分数与健康者无显著差异,提示该自动化技术可检测亚临床左心室异常。

要点

  • 化疗后乳腺癌患者左心室射血分数与健康者无显著差异(59±6% vs 63±6%,p=0.1)。
  • 患者基底径较健康者增大(5.0±0.5 cm vs 4.4±0.5 cm,p<0.01),整体纵向应变减低(-0.15±0.02 vs -0.21±0.04,p<0.001)。
  • 患者心尖扭转较健康者减低(6.0±1.1° vs 9.7±1.4°,p<0.001),提示亚临床收缩功能异常。

核心结论

  • 统计分析结果提示,与健康者相比,化疗后患者可能存在左心室异常,表现为基底径增大及纵向应变和扭转减低。

研究设计与样本

  • 研究纳入21例女性化疗后乳腺癌患者和21例年龄匹配健康女性,采用位移编码受激回波(DENSE)序列采集数据,并使用基于量化边界检测、图像相位解缠和无网格径向点插值法的自动化MRI左心室收缩功能分析工具测量左心室腔量化指标、三维应变及扭转;DENSE测得的左心室腔量化指标与稳态自由进动测量结果进行对比验证,应变结果通过Bland-Altman观察者间一致性验证。

诊断标准与关键数值

  • 重复测量分析显示DENSE与稳态自由进动测得的左心室腔量化指标相似,其中心输出量为4.7±0.4 L vs 4.6±0.4 L(p=0.8),左心室射血分数为59±6% vs 58±5%(p=0.2)。患者与健康者间差异包括基底径5.0±0.5 cm vs 4.4±0.5 cm(p<0.01)、心尖扭转6.0±1.1° vs 9.7±1.4°(p<0.001)及整体纵向应变-0.15±0.02 vs -0.21±0.04(p<0.001),但左心室射血分数无显著差异(59±6% vs 63±6%,p=0.1)。

临床应用与阅片要点

  • 本研究表明,采用自动化技术综合评估收缩参数可检测化疗后乳腺癌患者的亚临床左心室异常。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: This study investigated the occurrence of cardiotoxicity-related left-ventricular (LV) contractile dysfunction in breast cancer patients following treatment with antineoplastic chemotherapy agents.

METHODS: A validated and automated MRI-based LV contractility analysis tool consisting of quantization-based boundary detection, unwrapping of image phases and the meshfree Radial Point Interpolation Method was used toward measuring LV chamber quantifications (LVCQ), three-dimensional strains and torsions in patients and healthy subjects. Data were acquired with the Displacement Encoding with Stimulated Echoes (DENSE) sequence on 21 female patients and 21 age-matched healthy females. Estimates of patient LVCQs from DENSE acquisitions were validated in comparison to similar steady-state free precession measurements and their strain results validated via Bland-Altman interobserver agreements. The occurrence of LV abnormalities was investigated via significant differences in contractility measurements (LVCQs, strains and torsions) between patients and healthy subjects.

RESULTS: Repeated measures analysis showed similarities between LVCQ measurements from DENSE and steady-state free precession, including cardiac output (4.7 ± 0.4 L, 4.6 ± 0.4 L, p = 0.8), and LV ejection fractions (59±6%, 58±5%, p = 0.2). Differences found between patients and healthy subjects included enlarged basal diameter (5.0 ± 0.5 cm vs 4.4 ± 0.5 cm, p < 0.01), apical torsion (6.0 ± 1.1° vs 9.7 ± 1.4°, p < 0.001) and global longitudinal strain (-0.15 ± 0.02 vs. -0.21 ± 0.04, p < 0.001), but not LV ejection fraction (59±6% vs. 63±6%, p = 0.1).

CONCLUSION: The results from the statistical analysis reveal the possibility of LV abnormalities in the post-chemotherapy patients via enlarged basal diameter and reduced longitudinal strain and torsion, in comparison to healthy subjects.

ADVANCES IN KNOWLEDGE: This study shows that subclinical LV abnormalities in post-chemotherapy breast cancer patients can be detected with an automated technique for the comprehensive analysis of contractile parameters.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Kar J, Cohen MV, McQuiston SA, et al. Fully automated and comprehensive MRI-based left-ventricular contractility analysis in post-chemotherapy breast cancer patients. Br J Radiol. 2019. PMID: 31617732. doi:10.1259/bjr.20190289

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。